VBI Vaccines Inc reports results for the quarter ended in September - Earnings Summary

VBI Vaccines

08/11/2021 14:32

* VBI Vaccines Inc  VBIV.OQ  reported a quarterly adjusted loss
of 6 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 7 cents per share.
* Revenue fell 64.1% to $107.00 thousand from a year ago; 
analysts expected $203.67 thousand. 
* VBI Vaccines Inc's reported EPS for the quarter was a loss
of 6 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* VBI Vaccines Inc shares had fallen by 4.2% this quarter and
gained 8.4% so far this year.
* The company reported a quarterly loss of $15.85 million.
* Wall Street's median 12-month price target for VBI Vaccines
Inc is $8.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 02:32 p.m.
 ​All figures in US dollars unless otherwise stated